Advisory - Unauthorized "Libigrow" Found on the Québec Market
OTTAWA, March 15, 2013 /CNW/ -
An unauthorized natural health product, "Libigrow" was tested by Health Canada and found to contain hidden ingredients (sildenafil and tadalafil) that may pose serious risks to the health of Canadians. "Libigrow" was being sold at two retail locations in the province of Québec: Boutique Sexie folie Inc. (Sainte-Catherine) and at Boutique Érotique 5ième avenue Inc. (Valleyfield).
This product is promoted as a male sexual stimulant and contains hidden prescription medications. Approved drugs that contain these medications can only be sold with a prescription and by a pharmacy. The purchase of such products elsewhere can put your health at serious risk.
Who is affected:
Canadians who have purchased or used these products, particularly people with heart problems.
What consumers should do:
What Health Canada is doing:
Boutique Sexie folie Inc. consented to forfeit its supply of "Libigrow" to Health Canada inspectors. "Libigrow" was sold at Boutique Érotique 5ième Avenue until December 2012. Health Canada is also working with the Canada Border Services Agency to stop any further shipments of "Libigrow" from entering Canada. The product's manufacturer, as identified on the label, is H&K Nutraceuticals, located in Los Angeles.
Sildenafil and tadalafil are prescription medications that should only be used under the supervision of a health care practitioner. Products containing sildenafil or tadalafil should never be used by individuals taking any kind of nitrate drug (e.g. nitroglycerine) as they can cause potentially life-threatening low blood pressure.
Individuals with heart problems including high blood pressure, a history of heart attack, stroke, abnormal heart beat or chest pain are at higher risk of cardiovascular side-effects if they engage in sexual activity, including if they use sildenafil or tadalafil to help them achieve an erection. Other possible side-effects of using sildenafil or tadalafil include headache, facial flushing, indigestion, dizziness, abnormal vision and hearing loss.
1.Libigrow - http://files.newswire.ca/1043/Products_affected.pdf
For more information:
Consumers and health professionals wanting more information about this advisory from Health Canada can contact the Public Enquiries Line at 613-957-2991, or toll free at 1-866-225-0709.
Media enquiries related to this Advisory should be directed to Health Canada Media Relations at 613-957-2983.
How to report side effects to health products:
To report suspected adverse reaction to these or other health products, please contact Health Canada's Canada Vigilance Program toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form and send to us using one of these methods:
- Fax: 1-866-678-6789
- Internet: www.healthcanada.gc.ca/medeffect
Mail: Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, ON, Address Locator 0701E
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.
Également disponible en français
SOURCE Health Canada